Johnson & Johnson News
Most Popular Johnson & Johnson Story
Johnson & Johnson/Synthes - Top 10 medical device deals of 2011
Companies: J&J/SynthesValue: $21.3 billion Scoop: In April, Johnson & Johnson ($JNJ) announced the biggest deal of the year with its intention to buy Switzerland's Synthes for $21.3 billion Read more >>
Latest Headlines
- January 30, 2012
- January 24, 2012
- January 11, 2012
- January 5, 2012
- December 12, 2011
- September 13, 2011
- September 9, 2011
- August 31, 2011
- July 15, 2011
- June 23, 2011
- June 15, 2011
- June 7, 2011
- April 27, 2011
- April 16, 2011
- April 10, 2011
- March 8, 2011
- February 22, 2011
- February 11, 2011
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
